GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.
Talaxis still hold 6.6p warrants that expire 31 Dec 2020 so not all warrants expire this week. Only the initial ones issued at IPO.
nice buys on the bell (not mine). I did manage to pick up another 60,000 to average down a little though so all good.
June
can't get a quote at the moment...
agreed. but this is screaming 'BUYZONE' to me.
you're both forgetting they don't have a licence to mine from the Malawi govt on any of their projects as yet. This was mentioned on the recently released technical report.
It should be a formality, however, it is a potential spanner in the works...
No, because the Talaxis investment is in Lancaster Exploration, which owns the Songwe licence, not Mkango. So Talaxis don't have 49% of Mkango, they have 49% of Lancaster Exploration, which owns the Songwe licence.
Make sense?
I think you also need to look at debt as well as cash. Its all there in the accounts. They pretty much balance each other out.
If you're thinking of investing you also need to weigh in the risk of renewing the relevant licences with the Malawi govt as that is a potential banana skin if they ever decided to pull the plug it would render all 3x projects worthless.
I'm not deramping as I am invested but there are a few facts here that many people on this bb seem to forget. If you read the annual report it's all in there.
In 18-24 months this could be 70p (or could be taken over at god knows what price) or could be nothing. It's not a dead cert by any means.
Very interesting indeed. Not sure RBW warranted the 44% uplift in share price mind you... they should be looking to do a deal with Talaxis, although I believe there is an ongoing probe by the Singaporean authorities into Noble Group which could be holding the SP back potentially. Whilst the Noble Group restructure took place in Dec 2018, the probe was announced a matter of days prior to completion and is still ongoing at this point.
i stand corrected :) - you are right cb
basically Tiger... do some research on this then make your own decision. There are a fair few of us here who have been here since IPO or not long thereafter and have seen the story grow to a point where it looks financially solid now and imo we should really be looking at double the mCap we currently have, for starters...
They are basically at BFS stage with Talaxis (sub division - but technically, a separate legal entity linked to Noble Group) owning 49% of the co having invested £12M so far...
Talaxis have an option to raise their interest to 75% (for how much £ I'm not sure...) but if they do, it will ONLY be on the basis they have secured equity funding to production which would give MKA free carry on a project with an NPV of $245M.
This should pretty much tell you most of what you need to know...
The main exploration target in the 80% held Phalombe licence is the Songwe Hill rare earths deposit. This features carbonatite-hosted rare earth mineralisation and was subject to previous exploration in the late 1980s. Mkango completed an updated Pre-Feasibility Study for the project in November 2015 and a Feasibility Study is currently underway, the initial phases of which included a 10,900 metre drilling programme and updated mineral resource estimate.
Under the terms of an agreement with Talaxis, Talaxis will fully fund the Feasibility Study for Songwe by investing £12 million for a 49% interest in the project (via Mkango subsidiary Lancaster Exploration Ltd). Talaxis will also have the option to acquire a further 26% interest by arranging funding for project development including funding the equity component thereof. If Talaxis exercises its option, Mkango will retain a 25% interest, free carried to production. To-date, Talaxis has invested £5 million, which has funded the initial phases of the Feasibility Study, for a 20% interest in the project, with Mkango holding 80%.
By investing a further £2 million, Talaxis will acquire a 49% interest in Maginito Ltd, a new subsidiary of Mkango focused on neodymium alloy powders, magnets and other technologies. This includes the collaboration with Metalysis Ltd announced in September 2017, which is focused on advanced alloys using neodymium or praseodymium with other elements for permanent magnet manufacturing. Permanent magnets are critical materials for most electric vehicles, direct drive wind turbines and many other high growth applications. Neodymium is a key rare earth component at Songwe. To date, Talaxis has invested £1 million for a 24.5% interest in Maginito with Mkango holding 75.5%.
The main exploration targets in Mkango's remaining two 100% held licences are, in the Thambani licence, uranium, niobium, tantalum and zircon and, in the Chimimbe Hill licence, nickel and cobalt.
i'm waiting til end of the month at the earliest to top up.
Director purchase = Open period = No material news due = SP will continue to fall.
Stupid move by Nigel and badly advised.
have you read this: https://aibn.uq.edu.au/article/2018/03/spikey-nanoparticles-bind-and-protect-dna-delivery-cells
do we think this is linked to N4P? (read the last sentence in the article....)
forgive my ignorance - what is the yu group?
buys coming in on the bell. not huge, but interest definitely returning to the stock today. Looking forward to tomorrow now!
Looks like they've invested a bit of cash into the new marketing video. Reminds me of similar stuff that AVCT were putting together when they were seeking commercial partners.
New website definitely a good improvement on the last one. What do we all think?
Agreed. The more they are out and about at these kind of things the better. Can only help increase visibility longer term and means they're networking with the right people.
I know what you mean. If they want to communicate better with the investment community they should use the RNS-Reach (RNS-R) service which is for news outside of regulatory interest. That would give them a much wider audience than posting news in a hard to find area of their website.
Maybe they should redo their homepage so the news is frontpage if they are likely to keep up with the updates. That would also increase discoverability on search engines. Small beans I know, but every little helps.
All the recent news posted on their website and twitter feed does point towards they are putting themselves in the shop window which I think has upsides and a downside. The upside being that more commercial partners are obviously welcome... the downside being that if they feel the need to be doing such PR in order to attract commercial partners then maybe it is the case that we are a little thin on the ground as to where they possibly feel they should be.
It is notable that the company are no longer putting any timescales on where they think milestone payments are possible as was previously the case when the generics division was still going. I'm happy to sit and wait here. The Moderna IPO shows the potential with mRNA so let's see where Nigel gets us to by end of 2019...